Pharma spends the most to advertise less-effective drugs: Study

The pharmaceutical industry spends more money on advertising for drugs with lower health benefits than ones with high benefits, a new study shows, reports Healthleaders Media. Researchers at the Johns Hopkins Bloomberg School of Public Health found that the share of promotional spending allocated to advertising averaged 14.3 percentage points higher for drugs with low added benefit compared to drugs with high added benefit.